2025年9月24日, Forte生物科学、自然阳光和Kratos的禁闭协议到期, 允许内幕人士出售股份。 
On September 24, 2025, lock-up agreements for Forte Biosciences, Nature's Sunshine, and Kratos expire, allowing insiders to sell shares.
2025年9月24日, Forte生物科学、自然阳光产品以及Kratos国防和安全解决方案的封锁协议到期。 On September 24, 2025, lock-up agreements for Forte Biosciences, Nature's Sunshine Products, and Kratos Defense & Security Solutions expire. 这些限制从2025年6月25日起持续90至91天,禁止行政主管、董事和主要股东未经承保人批准出售、转让或套期保值其股份或可兑换证券。 These restrictions, lasting 90 to 91 days from June 25, 2025, prohibit executives, directors, and key shareholders from selling, transferring, or hedging their shares or convertible securities without underwriter approval. 规则适用于普通股,受限股份和预融资证券,旨在防止市场泛滥,并在公开发行后稳定股价. The rules apply to common stock, restricted stock units, and pre-funded warrants, aiming to prevent market flooding and stabilize stock prices after public offerings.
